BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34068955)

  • 1. Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences.
    Cabezas J; Llerena S; Mateo M; Álvarez R; Cobo C; González V; Martró E; Cuadrado A; Crespo J
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34068955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.
    Papaluca T; McDonald L; Craigie A; Gibson A; Desmond P; Wong D; Winter R; Scott N; Howell J; Doyle J; Pedrana A; Lloyd A; Stoove M; Hellard M; Iser D; Thompson A
    J Hepatol; 2019 May; 70(5):839-846. PubMed ID: 30654067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIPPOCRATES
    Gaspar R; Liberal R; Tavares J; Morgado R; Macedo G
    World J Hepatol; 2020 Dec; 12(12):1314-1325. PubMed ID: 33442457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting.
    Overton K; Clegg J; Pekin F; Wood J; McGrath C; Lloyd A; Post JJ
    Int J Drug Policy; 2019 Oct; 72():123-128. PubMed ID: 30967329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
    Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
    Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
    Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of telemedicine to hepatitis C elimination in a correctional facility.
    Jiménez Galán G; Alia Alia C; Vegue González M; García Berriguete RMª; Fernández González F; Fernández Rodríguez CM; González Fernández M; Gutiérrez García ML; Losa JE; Velasco M; Moreno L; Hervás R; Delgado-Iribarren A; Palacios García-Cervigón G
    Rev Esp Enferm Dig; 2019 Jul; 111(7):550-555. PubMed ID: 31215210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting.
    Cuadrado A; Cobo C; Mateo M; Blasco AJ; Cabezas J; Llerena S; Fortea JI; Lázaro P; Crespo J
    Int J Drug Policy; 2021 Feb; 88():103031. PubMed ID: 33221615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
    J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.
    Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D
    Clin Infect Dis; 2013 Apr; 56(8):1078-84. PubMed ID: 23362288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in Australian prisons: a national needs assessment.
    Mina MM; Herawati L; Butler T; Lloyd A
    Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
    Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
    BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania-A Population-Based Screening-The First Step to Viral Micro-Elimination.
    Huiban L; Stanciu C; Muzica CM; Cuciureanu T; Chiriac S; Zenovia S; Burduloi VM; Petrea O; Sîngeap AM; Gîrleanu I; Sfarti C; Cojocariu C; Trifan A
    Healthcare (Basel); 2021 May; 9(6):. PubMed ID: 34072635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recidivism in Switzerland: the influence of custodial sanctions.
    Gonçalves LC; Baggio S; Weber M; Urwyler T; Noll T; Singh JP; Rossegger A; Endrass J
    Swiss Med Wkly; 2021 Mar; 151():w20462. PubMed ID: 33793962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.
    Yanes-Lane M; Dussault C; Linthwaite B; Cox J; Klein MB; Sebastiani G; Lebouché B; Kronfli N
    J Viral Hepat; 2020 Feb; 27(2):205-220. PubMed ID: 31638294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project.
    Bartlett SR; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Dore GJ; Russell DB
    Clin Infect Dis; 2018 Jul; 67(3):460-463. PubMed ID: 29538639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.